Le Lézard
Classified in: Health, Science and technology

DuPont Brings Science-backed Quality and Innovation to Asia's Pharmaceutical Industry at CPhI China 2020

SHANGHAI, Nov. 30, 2020 /PRNewswire-PRWeb/ -- DuPont Nutrition & Biosciences (DuPont) will use insights to help manufacturers evolve with the biggest trends in the Asia pharma industry, with highlights to the latest offerings at CPhI China 2020 from December 16?18. Attendees who visit DuPont booth E3D26 will get an exclusive look at solutions to many of the industry's most pressing challenges, including taste-masking for pediatric medicines, pharmaceutical ingredients for acid reflux, and controlled release solutions that can significantly enhance manufacturing processes and much more.

DuPont has continuously supported its pharmaceutical customers with its vital expertise, and broad, unique portfolio that helps formulators succeed in manufacturing, regulatory, product design and beyond. As China's pharmaceutical industry continues to expand in profitability and regulatory complexity, DuPont intends to show customers that it has the products and technical know-how to help them keep pace.

Experts will be available to discuss the offerings which include:

At the booth, attendees can attend mini talks and discuss with DuPont experts on how they can enable their goals in the pharma and dietary supplements space, including sharing of best practices for each ingredient, application expertise and regulatory knowledge tailored to the Asian market.

"All of these offerings represent our commitment to delivering strategic, high quality customer service to the Asia's pharma industry," explained Frank Zhao, Sales Leader, APAC, Pharma Solutions, DuPont Nutrition & Biosciences. "It's a reflection of our global implementation of Big Q?a Quality culture. We believe our focus on quality will resonate with visitors at CPhI China, who will come away with practical solutions to create viable pharmaceutical products for this expanding market."

To learn more about the broad product portfolio and expertise areas from DuPont Nutrition & Biosciences, visit pharma.dupont.com.

About DuPont Nutrition & Biosciences
DuPont Nutrition & Biosciences applies expert science to advance market-driven, healthy and sustainable solutions for the food, beverage, dietary supplement and pharmaceutical industries. We also use cutting-edge biotechnology across a range of markets to advance bio-based solutions to meet the needs of a growing population, while protecting our environment for future generations. We are innovative solvers who help our customers turn challenges into high-value business opportunities. For more information: http://www.dupontnutritionandbiosciences.com.

About DuPont
DuPont (NYSE: DD) is a global innovation leader with technology-based materials, ingredients and solutions that help transform industries and everyday life. Our employees apply diverse science and expertise to help customers advance their best ideas and deliver essential innovations in key markets including electronics, transportation, construction, water, health and wellness, food, and worker safety. More information can be found at http://www.dupont.com. Investors can access information included on the Investor Relations section of the website at investors.dupont.com.

# # #

DuPonttm, the DuPont Oval Logo, and all trademarks and service marks denoted with tm, SM or ® are owned by affiliates of DuPont de Nemours, Inc. unless otherwise noted

Media Contact

Lindsay Torriero, DuPont, +1 407 701 2133, Lindsay.Torriero@dupont.com



These press releases may also interest you

at 23:30
Starting tomorrow, the Fourth Edition of the Future Investment Initiative (FII) will take place in five global hubs. In a world-first, Richard Attias & Associates (RA&A) is using ground-breaking XR (extended reality) technology with a multiplex...

at 22:35
GCL System Integration Technology Co. Ltd ("GCLSI " or "the Company")(Shenzhen:002506), a leading photovoltaics(PV) company in China, announced on January 21 that it successfully raised 2.5 billion yuan ($US386 million) through a private placement...

at 22:30
Casio Computer Co., Ltd. announced today the upcoming release of the DZ-D100 DERMOCAMERA that allows close-up shots with the lens directly touching the skin as well as ordinary shots, all using a single camera. The new product was created based on...

at 22:10
Personalis, Inc. , a leader in advanced genomics for population sequencing and cancer, today announced the pricing of its previously announced underwritten public offering of 3,950,000 shares of its common stock at a price to the public of $38.00 per...

at 22:10
Extreme Networks, Inc. , a cloud-driven networking company, today announced that it has changed the timing of its previously announced earnings conference call. The Company will now host a conference call to discuss financial results for its second...

at 22:00
Constellation Software Inc. announced today it will release its fourth quarter results on February 12, 2021. The Company's quarterly results will be disseminated via press release and made available on the Company's website (www.csisoftware.com)...

News published on 30 november 2020 at 22:30 and distributed by: